Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.29%
#2 Ocean Protocol Ocean Protocol +18.64%
#3 KUB Coin KUB Coin +12.98%
#4 Audiera Audiera +10.79%
#5 Perle Perle +10.63%
#6 Wiki Cat Wiki Cat +9.96%
#7 Geodnet Geodnet +9.46%
#8 Arowana Arowana +9.35%
#9 OpenEden OpenEden +8.17%
#10 DexNet DexNet +7.78%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc.

MPLT
Classement en actions #32256
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm... MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease. Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.
Prix de l'action
$13.43
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$10.60M
Changement (1 jour)
-4.26%
Changement (1 an)
-
Pays
US
Échange MapLight Therapeutics, Inc. (MPLT)

Catégorie

Healthcare
Le prix MPLT avec la capitalisation boursière de B
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.
MPLT
$13.43
Capitalisation boursière de MapLight Therapeutics, Inc.(MPLT)
Capitalisation boursière: $10.60M
En August 2026, MapLight Therapeutics, Inc. a une capitalisation boursière de $10.60M. Cela fait de MapLight Therapeutics, Inc. la 32256th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de MapLight Therapeutics, Inc. du 2025 au 2026
MPLT par rapport au top 5 des plus populaires stocks
Prix pour MPLT L’actif B La capitalisation boursière de B Résultats
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.
$6,917,375 $10.60M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.460T +51,496,049.54%
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.
$5,687,665 $10.60M
Apple Inc. Apple Inc.
AAPL
$4.489T +42,341,516.01%
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.
$5,246,037 $10.60M
Alphabet Inc. Alphabet Inc.
GOOG
$4.141T +39,053,836.73%
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.
$4,520,926 $10.60M
Microsoft Corporation Microsoft Corporation
MSFT
$3.569T +33,655,768.57%
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.
$3,544,784 $10.60M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.798T +26,388,918.99%